NVNO Stock Analysis: Buy, Sell, or Hold?
NVNO - enVVeno Medical Corporation Common Stock
$9.94
-0.28 (-2.74%)
▼
5d:
-5.33%
30d:
-9.22%
90d:
+6.31%
HOLD
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Get Alerted When NVNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NVNO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NVNO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NVNO is currently trading at $9.94, which is considered oversold relative to its 30-day fair value range of $10.21 to $12.06.
Technical Outlook: Technically, NVNO is in a strong uptrend. The price is currently testing key support at $9.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.50 (+25.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NVNO is in a strong uptrend. The price is currently testing key support at $9.88. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.50 (+25.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.21 -
$12.06
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.8% below Wall St target ($12.50)
- CAUTION: Recommendation downgraded due to -5.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$10.21 -
$12.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.88
Resistance Level
$12.54
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.94
Wall Street Target
$12.50
(+25.8%)
Share & Embed Analysis
Last updated: May 09, 2026 8:04 PM ET
Data refreshes hourly during market hours. Next update: 9:04 PM
Data refreshes hourly during market hours. Next update: 9:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis Duhay
SELL
140 shares
2026-03-12
Francis Duhay
SELL
140 shares
2025-12-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 58 HOLD |
